Cargando…

Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies

Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide, being characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Among several putative factors that may contribute to PD pathogenesis, inflammatory mechanisms may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rocha, Natália Pessoa, de Miranda, Aline Silva, Teixeira, Antônio Lúcio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532803/ https://www.ncbi.nlm.nih.gov/pubmed/26295044 http://dx.doi.org/10.1155/2015/628192

Ejemplares similares

Neuropsychiatric Disorders in Chronic Kidney Disease
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2019)

Biomarker of Neuroinflammation in Parkinson’s Disease
por: Liu, Tsai-Wei, et al.
Publicado: (2022)

Clinical Predictors of Excessive Daytime Sleepiness in Patients with Parkinson's Disease
por: Junho, Bruno Terra, et al.
Publicado: (2018)

Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation
por: Moore, Amy H., et al.
Publicado: (2010)

Neuroinflammation and anti-inflammatory therapy for ischemic stroke
por: Cao, Yangyue, et al.
Publicado: (2023)

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
por: Araújo, Bruna, et al.
Publicado: (2022)

Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson’s Disease
por: Chen, Kun, et al.
Publicado: (2023)

Glycosphingolipids and neuroinflammation in Parkinson’s disease
por: Belarbi, Karim, et al.
Publicado: (2020)

Promises and pitfalls of immune-based strategies for Huntington's disease
por: Colpo, Gabriela Delevati, et al.
Publicado: (2017)

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker Discovery
por: Picca, Anna, et al.
Publicado: (2021)

Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease
por: Rocha, Natália Pessoa, et al.
Publicado: (2014)

Gene Expression Profiling in Huntington’s Disease: Does Comorbidity with Depressive Symptoms Matter?
por: Colpo, Gabriela Delevati, et al.
Publicado: (2020)

Renin-angiotensin system in the central nervous system: focus on Huntington’s disease
por: de Miranda, Aline Silva, et al.
Publicado: (2023)

Coronavirus Disease-2019 Conundrum: RAS Blockade and Geriatric-Associated Neuropsychiatric Disorders
por: de Miranda, Aline Silva, et al.
Publicado: (2020)

Cyclooxygenase and Neuroinflammation in Parkinson’s Disease Neurodegeneration
por: Bartels, Anna L, et al.
Publicado: (2010)

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
por: Gelders, Géraldine, et al.
Publicado: (2018)

The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
por: Badanjak, Katja, et al.
Publicado: (2021)

Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
por: Rasheed, Madiha, et al.
Publicado: (2021)

Microglia Mediated Neuroinflammation in Parkinson’s Disease
por: Isik, Sevim, et al.
Publicado: (2023)

Neuroinflammation, Microglia and Implications for Anti-Inflammatory Treatment in Alzheimer's Disease
por: Krause, Daniela L., et al.
Publicado: (2010)

Cognitive evaluation in Parkinson's disease: applying the Movement Disorder Society recommendations in a population with a low level of formal education
por: Rocha, Natalia Pessoa, et al.
Publicado: (2023)

Evidences of hydroxytyrosol as an anti-inflammatory agent in Parkinson’s disease: insights into the mechanisms of action
por: Hornedo-Ortega, Ruth, et al.
Publicado: (2020)

Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium
por: Conti, Elisa, et al.
Publicado: (2020)

Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria
por: Miranda, Aline S, et al.
Publicado: (2013)

Clinical Characteristics, Iron Metabolism and Neuroinflammation: New Insight into Excessive Daytime Sleepiness in Parkinson’s Disease
por: Hu, Yang, et al.
Publicado: (2021)

Renin angiotensin system in liver diseases: Friend or foe?
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2017)

The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
por: Zinger, Anna, et al.
Publicado: (2011)

The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
por: Tufekci, Kemal Ugur, et al.
Publicado: (2011)

Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation
por: Belloli, Sara, et al.
Publicado: (2020)

Neuroinflammation and protein pathology in Parkinson’s disease dementia
por: Kouli, Antonina, et al.
Publicado: (2020)

Neuroinflammation in Parkinson’s Disease and its Treatment Opportunities
por: Çınar, Elif, et al.
Publicado: (2022)

Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives
por: Minchev, Danail, et al.
Publicado: (2022)

The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
por: Jurcau, Anamaria, et al.
Publicado: (2023)

Revisiting the neuropsychiatry of Huntington's disease
por: Teixeira, Antonio Lucio, et al.
Publicado: (2016)

Neuroinflammation in inflammatory bowel disease
por: Lakhan, Shaheen E, et al.
Publicado: (2010)

Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models
por: Park, Jung-Eun, et al.
Publicado: (2022)

Oxidative Stress in Microbial Diseases: Pathogen, Host, and Therapeutics
por: Novaes, Rômulo Dias, et al.
Publicado: (2019)

The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson’s disease mouse models
por: Lee, Yu-Young, et al.
Publicado: (2019)

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
por: Russo, Isabella, et al.
Publicado: (2014)

Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease
por: More, Sandeep Vasant, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gandttvn8il0l06rgqnuh6rjkm